Pfizer Inc. PFE
NYSE
Recommendation
Dividend Power Score
Day's Range
$28.95$29.38
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/27/2026 | 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 63.62B | 63.70B | -- | -- | -- |
| Total Other Revenue | 1.00M | 1.00M | -- | -- | -- |
| Total Revenue | 63.63B | 63.70B | -- | -- | -- |
| Cost of Revenue | 15.97B | 16.11B | -- | -- | -- |
| Gross Profit | 47.65B | 47.59B | -- | -- | -- |
| SG&A Expenses | 12.95B | 12.92B | -- | -- | -- |
| Depreciation & Amortization | 4.73B | 4.82B | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.13B | 44.86B | -- | -- | -- |
| Operating Income | 18.50B | 18.84B | -- | -- | -- |
| Income Before Tax | 4.26B | 4.21B | -- | -- | -- |
| Income Tax Expenses | 186.00M | -164.00M | -- | -- | -- |
| Earnings from Continuing Operations | 4.07K | 4.37K | -- | -- | -- |
| Earnings from Discontinued Operations | -5.00M | -5.00M | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -36.00M | -35.00M | -- | -- | -- |
| Net Income | 4.03B | 4.33B | -- | -- | -- |
| EBIT | 18.50B | 18.84B | -- | -- | -- |
| EBITDA | 24.94B | 25.38B | -- | -- | -- |
| EPS Basic | 0.71 | 0.76 | -- | -- | -- |
| Normalized Basic EPS | 2.06 | 2.08 | -- | -- | -- |
| EPS Diluted | 0.69 | 0.75 | -- | -- | -- |
| Normalized Diluted EPS | 2.06 | 2.08 | -- | -- | -- |
| Average Basic Shares Outstanding | 22.78B | 22.76B | -- | -- | -- |
| Average Diluted Shares Outstanding | 22.87B | 22.83B | -- | -- | -- |
| Dividend Per Share | 2.15 | 2.15 | -- | -- | -- |
| Payout Ratio | 242.80% | 225.88% | -- | -- | -- |